195 related articles for article (PubMed ID: 26507946)
21. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system.
Gui W; Wang W; Jiao X; Chen L; Wen Y; Zhang X
Chemphyschem; 2015 Feb; 16(3):607-13. PubMed ID: 25492672
[TBL] [Abstract][Full Text] [Related]
22. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
23. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
Cui Y; Dong H; Cai X; Wang D; Li Y
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
[TBL] [Abstract][Full Text] [Related]
24. Phosphonated Pillar[5]arene-Valved Mesoporous Silica Drug Delivery Systems.
Huang X; Wu S; Ke X; Li X; Du X
ACS Appl Mater Interfaces; 2017 Jun; 9(23):19638-19645. PubMed ID: 28530792
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Fluorescence Imaging and Photodynamic Cancer Therapy Using Hollow Mesoporous Nanocontainers.
Hong SH; Kim H; Choi Y
Chem Asian J; 2017 Jul; 12(14):1700-1703. PubMed ID: 28463441
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
27. Pillar[6]arene-valved mesoporous silica nanovehicles for multiresponsive controlled release.
Huang X; Du X
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20430-6. PubMed ID: 25336021
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
29. Mechanized silica nanoparticles based on reversible bistable [2]pseudorotaxanes as supramolecular nanovalves for multistage pH-controlled release.
Wang M; Chen T; Ding C; Fu J
Chem Commun (Camb); 2014 May; 50(39):5068-71. PubMed ID: 24714998
[TBL] [Abstract][Full Text] [Related]
30. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
31. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ
Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109
[TBL] [Abstract][Full Text] [Related]
32. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy.
Chen X; Liu Z
Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
34. Silica nanoparticle surface chemistry: An important trait affecting cellular biocompatibility in two and three dimensional culture systems.
Hasany M; Taebnia N; Yaghmaei S; Shahbazi MA; Mehrali M; Dolatshahi-Pirouz A; Arpanaei A
Colloids Surf B Biointerfaces; 2019 Oct; 182():110353. PubMed ID: 31336281
[TBL] [Abstract][Full Text] [Related]
35. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery.
Tian Z; Xu Y; Zhu Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731
[TBL] [Abstract][Full Text] [Related]
36. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
37. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
38. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
39. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
Xiao D; Jia HZ; Ma N; Zhuo RX; Zhang XZ
Nanoscale; 2015 Jun; 7(22):10071-7. PubMed ID: 25978679
[TBL] [Abstract][Full Text] [Related]
40. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
